Harbor Capital Advisors Inc. lifted its stake in HealthStream, Inc. (NASDAQ:HSTM - Free Report) by 141.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 400,033 shares of the technology company's stock after acquiring an additional 234,148 shares during the period. Harbor Capital Advisors Inc. owned 1.32% of HealthStream worth $11,537,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently modified their holdings of HSTM. GAMMA Investing LLC grew its position in HealthStream by 172.1% during the 2nd quarter. GAMMA Investing LLC now owns 996 shares of the technology company's stock worth $28,000 after purchasing an additional 630 shares in the last quarter. Point72 DIFC Ltd acquired a new position in HealthStream during the 2nd quarter worth $38,000. Copeland Capital Management LLC bought a new position in shares of HealthStream in the third quarter worth about $63,000. CWM LLC grew its holdings in HealthStream by 405.4% in the 2nd quarter. CWM LLC now owns 2,709 shares of the technology company's stock valued at $76,000 after buying an additional 2,173 shares during the last quarter. Finally, XTX Topco Ltd bought a new stake in HealthStream in the 2nd quarter valued at $214,000. 69.58% of the stock is currently owned by institutional investors and hedge funds.
HealthStream Stock Up 0.3 %
HSTM traded up $0.09 during trading on Friday, reaching $29.33. 115,529 shares of the stock traded hands, compared to its average volume of 124,801. HealthStream, Inc. has a 12 month low of $23.92 and a 12 month high of $31.15. The stock's 50-day moving average is $28.80 and its 200 day moving average is $28.08. The stock has a market capitalization of $892.22 million, a PE ratio of 45.12, a P/E/G ratio of 3.89 and a beta of 0.35.
HealthStream (NASDAQ:HSTM - Get Free Report) last announced its quarterly earnings data on Monday, October 21st. The technology company reported $0.19 EPS for the quarter, beating analysts' consensus estimates of $0.13 by $0.06. HealthStream had a return on equity of 5.67% and a net margin of 6.84%. The firm had revenue of $73.10 million during the quarter, compared to analysts' expectations of $73.53 million. During the same quarter last year, the firm posted $0.13 earnings per share. The company's revenue for the quarter was up 4.0% compared to the same quarter last year. As a group, equities research analysts anticipate that HealthStream, Inc. will post 0.63 EPS for the current year.
HealthStream Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be given a $0.028 dividend. This represents a $0.11 annualized dividend and a yield of 0.38%. The ex-dividend date is Monday, November 4th. HealthStream's dividend payout ratio is 16.92%.
Analyst Upgrades and Downgrades
HSTM has been the subject of several recent research reports. Canaccord Genuity Group increased their price target on shares of HealthStream from $28.00 to $29.00 and gave the stock a "hold" rating in a research report on Wednesday, October 23rd. StockNews.com lowered HealthStream from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, July 24th. Barclays raised their price target on HealthStream from $32.00 to $34.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 23rd. Finally, Craig Hallum upgraded HealthStream to a "strong-buy" rating in a research note on Thursday, October 17th. Two investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, HealthStream has an average rating of "Moderate Buy" and a consensus price target of $31.50.
Read Our Latest Stock Report on HealthStream
Insider Activity at HealthStream
In other HealthStream news, SVP Kevin P. O'hara sold 3,000 shares of the firm's stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the completion of the transaction, the senior vice president now owns 9,527 shares in the company, valued at $267,041.81. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, SVP Kevin P. O'hara sold 3,000 shares of the stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total transaction of $84,090.00. Following the transaction, the senior vice president now directly owns 9,527 shares in the company, valued at approximately $267,041.81. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Tate Deborah Taylor sold 1,400 shares of the company's stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $28.53, for a total transaction of $39,942.00. Following the completion of the sale, the director now directly owns 22,326 shares of the company's stock, valued at $636,960.78. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 20.60% of the stock is owned by company insiders.
About HealthStream
(
Free Report)
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
Further Reading
Before you consider HealthStream, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthStream wasn't on the list.
While HealthStream currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.